Researchers at the Carnegie Institution for Science, Johns Hopkins University and the Mayo Clinic have reportedly leveraged “state-of-the-art” genome editing to track lipoprotein movement in real time, allowing scientists a glimpse into how cholesterol moves, accumulates and gathers to build plaque.

An antioxidant compound found in soybeans might protect the heart from cannabis-related CV damage, according to work presented at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions.

The odds a heart patient will experience complications after they’re implanted with a cardiac device vary depending on where they receive care, according to work published in the Annals of Internal Medicine July 30.

A study published in JAMA Cardiology July 24 suggests high-intensity statin use after MI depends on where patients live in the U.S., with 66% higher use in New England than in the country’s West South Central region.

Sixty-nine people have survived out-of-hospital cardiac arrests at Hawaii’s airports since an AED program was first implemented in 2006, the Oregonian reports.

Swiss drugmaker Novartis on July 29 announced its combo sacubitril/valsartan drug Entresto “narrowly missed” its primary endpoint in the Phase III PARAGON-HF study, throwing into question the future of a blockbuster drug.

Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.

KentuckyOne Health will suspend its heart transplant program at Jewish Hospital effective August 17, leaving 32 patients in Louisville, Ky., without a clear path to a new heart.